Table 2. Characteristics of the 65 ccRCC patients included in the TCGA series (US) using RNA-Sequencing technology.
| Characteristics | Male | Female | p-value* | ||||
| N | % | N | % | ||||
| Total (N = 65) | 46 | 70.8 | 19 | 29.2 | |||
| Age | **0.375 | ||||||
| 38–44 | 4 | 8.7 | 2 | 10.5 | |||
| 45–54 | 9 | 19.6 | 3 | 15.8 | |||
| 55–64 | 14 | 30.4 | 4 | 21.1 | |||
| 65–74 | 10 | 21.7 | 8 | 42.1 | |||
| 75–90 | 9 | 19.6 | 2 | 10.5 | |||
| Age, Mean ± SD | 62.87 (±12.9) | 62.84 (±11.2) | 0.994 | ||||
| Grade | ***0.358 | ||||||
| Well-differentiated | 0 | 0 | 1 | 5.3 | |||
| Moderately differentiated | 16 | 34.8 | 8 | 42.1 | |||
| Poorly differentiated | 20 | 43.5 | 6 | 31.6 | |||
| Undifferentiated | 9 | 19.6 | 3 | 15.8 | |||
| Missing | 1 | 2.2 | 1 | 5.3 | |||
| Stage □ | ***0.821 | ||||||
| I | 16 | 34.8 | 7 | 36.8 | |||
| II | 6 | 13.0 | 1 | 5.3 | |||
| III | 11 | 23.9 | 5 | 26.3 | |||
| IV | 10 | 21.7 | 5 | 26.3 | |||
| Missing | 3 | 6.5 | 1 | 5.3 | |||
Data from all paired tumour/non-tumour sets available on April 19, 2012 were retrieved from TCGA data portal.
*
p value calculated using Pearson χ2 testing for categorical variables and t-test for continuous variables.
**
the younger two categories were grouped.
***
excluding missing category.
□
Of stage IV patients 15 had distant metastasis at diagnosis, and by definition none of stage I, II or III patients had distant metastasis. Missing stages were due to the lack of lymph nodes and/or metastasis evaluation>. These four patients were pT1aNXMX, pT3aNXM0, pT1bNXMX and pT3aNXMX, respectively.